| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.26 | 0.08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |